clinical trial · NCT07177352
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Hoffmann-La Roche·phase3·recruiting·n = 13,000
Alzheimers DiseaseNo Intervention
brief summary
This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.
started
Jul 2, 2025
primary completion
Jul 31, 2035
completion
Jul 31, 2035
last updated
Apr 6, 2026
official title
Master Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies as Assessed by Biomarker Status and Cognition
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol